A Phase 3, Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy ofStereotactic Body Radiotherapy (SBRT) with or without Pembrolizumab (MK-3475) in Participants withMedically Inoperable Stages I or IIA Non Small Cell Lung C

Project: Research project

Project Details

Description

A Phase 3, Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Stereotactic Body Radiotherapy (SBRT) with or without Pembrolizumab (MK-3475) in Participants with Medically Inoperable Stages I or IIA Non Small Cell Lung C
StatusActive
Effective start/end date5/2/195/31/24

Funding

  • MERCK, SHARP & DOHME CORP

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.